171 related articles for article (PubMed ID: 10578134)
21. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
22. Do alpha 2-adrenoceptors and imidazoline binding sites coexist in the human term placenta? Evidence from direct binding studies.
Bagaméry K; Kovács L; Nyári T; Falkay G
Mol Hum Reprod; 1998 Apr; 4(4):387-91. PubMed ID: 9620839
[TBL] [Abstract][Full Text] [Related]
23. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
Virtanen R; Savola JM; Saano V
Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
[TBL] [Abstract][Full Text] [Related]
24. [3H]RX821002 (2-methoxyidazoxan) binds to alpha 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney.
Callado LF; Gabilondo AM; Meana JJ
Eur J Pharmacol; 1996 Dec; 316(2-3):359-68. PubMed ID: 8982708
[TBL] [Abstract][Full Text] [Related]
25. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
26. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
O'Rourke MF; Blaxall HS; Iversen LJ; Bylund DB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
[TBL] [Abstract][Full Text] [Related]
27. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
Mustonen P; Savola J; Lassila R
Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789
[TBL] [Abstract][Full Text] [Related]
28. Quantitative in vitro and ex vivo autoradiography of the alpha 2-adrenoceptor antagonist [3H]atipamezole.
Biegon A; Mathis CA; Budinger TF
Eur J Pharmacol; 1992 Nov; 224(1):27-38. PubMed ID: 1360406
[TBL] [Abstract][Full Text] [Related]
29. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
30. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1998 Jul; 353(1):123-35. PubMed ID: 9721049
[TBL] [Abstract][Full Text] [Related]
31. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
32. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.
King PR; Gundlach AL; Louis WJ
Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138
[TBL] [Abstract][Full Text] [Related]
33. Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
Callado LF; Meana JJ
Eur J Pharmacol; 1997 Jul; 332(1):109-12. PubMed ID: 9298931
[TBL] [Abstract][Full Text] [Related]
34. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
35. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
Uhlén S; Wikberg JE
Br J Pharmacol; 1991 Nov; 104(3):657-64. PubMed ID: 1665747
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor.
Hudson AL; Robinson ES; Lalies MD; Tyacke RJ; Jackson HC; Nutt DJ
J Auton Pharmacol; 1999 Dec; 19(6):311-20. PubMed ID: 10961736
[TBL] [Abstract][Full Text] [Related]
37. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Langin D; Paris H; Lafontan M
Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
[TBL] [Abstract][Full Text] [Related]
38. [3H]idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites.
Molderings GJ; Kundt L; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):252-7. PubMed ID: 7824041
[TBL] [Abstract][Full Text] [Related]
39. Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells.
Senard JM; Langin D; Estan L; Paris H
Eur J Pharmacol; 1990 Nov; 191(1):59-68. PubMed ID: 1982658
[TBL] [Abstract][Full Text] [Related]
40. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
MacKinnon AC; Redfern WS; Brown CM
Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
